Oxford (ots/PRNewswire) - The World Health Organization (WHO) has posted the conclusions and recommendations of the Vector Control Advisory Group (VCAG) meeting from March 14-15, 2016, regarding vector control tools for use in response to the recent Zika virus outbreak. After their review of several new tools with the potential to reduce vector populations, the VCAG ...
Ballerup, Denmark (ots/PRNewswire) - The marketing approval of Enstilar® would make it the first fixed combination topical foam treatment for people living with psoriasis vulgaris in the EU. LEO Pharma today announced that it received scientific approval of Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis ...
St. Gallen (ots) - ForaCare Suisse AG located in St. Gallen, Switzerland, announced today its Diamond GD50 health monitoring device is featured in the "United4Health European Project" via its partnership with Meter Ltd., FORA's Italian distributor. The United4Health European Project aims to demonstrate the value of ...
Gothenburg, Sweden (ots/PRNewswire) - Isofol Medical AB, a clinical stage pharmaceutical company, developing novel products for unmet needs within oncology, will use the investment to support the clinical program with Modufolin®, Isofol's lead drug candidate. Modufolin® is a novel folate-based compound being ...
Moscow (ots/PRNewswire) - UC RUSAL (SEHK: 486; Euronext: RUSAL/RUAL; Moscow Exchange: RUAL/RUALR), a leading global aluminium producer, co-organized a roundtable discussion "Ebola vaccine from Russia: the first lessons and outlook into the future". The Minister of Health, Veronika Skvortsova and the Head of the Russian Federal Service for Surveillance on Consumer ...
Milan (ots/PRNewswire) - GfK has announced its latest figures for key European optics markets (Italy, France, Spain and Germany), confirming a turnover of over EUR17 billion for total year 2015. GfK's Optics Panel tracks sales data for sunglasses, frames, spectacle lenses, contact lenses and care products for contact lenses. The 2015 figures show a 7.0 percent growth in sales value for the optical market across Italy, ...
Oxford, England (ots/PRNewswire) - The US Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) today released in the Federal Register a preliminary finding of no significant impact (FONSI) on Oxitec's self-limiting OX513A Aedes aegypti mosquito for an investigational trial in the Florida Keys. The finding agrees with the draft environmental ...
Athens, Greece (ots/PRNewswire) - Topline-results of the first randomised clinical trial in the world to investigate the effects of a nutritional intervention in very early AD (pre-dementia) [1] Topline results from the European LipiDiDiet clinical trial were presented today as part of a late-breaking presentation ...
London (ots/PRNewswire) - Direct access to the morning after pill in pharmacy has made making asmart, positive decision easier, for women not ready to have a baby New research, released on International Women's Day, shows that across Europe, more than three in four women (77%) are aware of the morning after pill as an option for managing the risk of an unplanned ...
Tolochenaz, Switzerland (ots/PRNewswire) - European innovation delivers titanium family of cages to support twin surgical objectives of bone fusion and sagittal realignment for improved patients' outcomes. Medtronic PLC (NYSE: MDT), the global leader in medical technology, today announced the launch of AVILA(TM), its new family of interbody fusion devices for L2-S1 levels in open and minimally invasive ALIF and OLIF ...
Ballerup, Denmark (ots/PRNewswire) - Data presented in a Late Breaking Science session at the 74th Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C. demonstrate that calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) foam formulation is a stable supersaturated solution ...
Chertsey, England (ots/PRNewswire) - Astellas Pharma Europe Ltd., a subsidiary of Astellas Pharma Inc. (TSE:4503), is pleased to announce that Mr Yukio Matsui has been appointed as President of EMEA Operations, with responsibility for the company's commercial operations in Europe, the Middle East and Africa. Yukio will assume his new position on 1st April 2016. Since ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company today announces that the Tokyo District Court granted Debiopharm an overall victory for the first instance demanding the suspension of patent infringement of ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") reminds shareholders of important developments relating to the Company's Income Access Share arrangements ("IAS Arrangements"). All shareholders who wish to receive, or continue to receive, UK sourced dividends via the IAS Arrangements (and ...
Hitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe Holding AG
Glasgow, Scotland (ots/PRNewswire) - This material is intended for European and UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the first once-daily combination of a long-acting basal insulin ...
Paris and London (ots/PRNewswire) - New Agreement Provides Healthcare Professionals with Streamlined, Cost-Effective Options for Accessing the CyberKnife® and TomoTherapy® Systems Accuray Europe and GE Capital Healthcare Equipment Finance announced today they have signed a collaboration agreement to develop ...
London (ots/PRNewswire) - ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the 41 week phase IIa ECLAIR study, which evaluated the safety, tolerability, dosing and satisfaction with the ...
Astellas Pharma Europe Limited
Chertsey, England (ots/PRNewswire) - Experts say the knock-on effect of lack of planning for later life, as highlighted in poll conducted for this year's ASTELLAS INNOVATION DEBATE[TM],will further impact upon stretched NHS resources Results from a new survey for the annual Astellas Innovation Debate have ...
London (ots/PRNewswire) - 32 week maintenance data presented at CROI showed comparable viral suppression rates between injectable regimen and three drug oral regimen ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented ...
Cork, Ireland (ots/PRNewswire) - Intramuscular 2-drug maintenance therapy demonstrates comparable antiviral activity to daily oral 3-drug combination Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, (Janssen) announced 32-week data from an ongoing phase IIb study. A ...
London (ots/PRNewswire) - GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has completed two previously announced transactions with Bristol-Myers Squibb to acquire its late-stage HIV ...
Lyon, France (ots/PRNewswire) - Results of review-based evidence on the public healthvalue of vaccination for seniors in Europe presented at WAidid congress The first Biennial Congress of the World Association for Infectious Diseases and Immunological Disorders (WAidid), has been held in Milan on February 18-20, ...
Lyon, France (ots/PRNewswire) - This decision opens the way to making Vaxelis® available to infants and toddlers in European countries Sanofi Pasteur MSD announced today that the European Commission has granted the marketing authorization for Vaxelis®, a new fully-liquid hexavalent vaccine indicated for primary and booster vaccination of infants and toddlers from the ...
Tokyo (ots/PRNewswire) - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that its European subsidiary, Daiichi Sankyo Europe GmbH Group (headquartered in Munich, Germany; hereafter, DSE), has granted exclusive rights to Merck & Co, Inc., Kenilworth, NJ, USA (NYSE: MRK), known as MSD outside the US and Canada (hereafter, MSD) to market the oral, once-daily anti-coagulant, LIXIANA® (edoxaban), ...
Sunnyvale, California (ots/PRNewswire) - Accuray Conference Focused on Trends in Radiation Oncology Accuray Incorporated (NASDAQ: ARAY) announced today highlights from their European AERO(TM) (Accuray Exchange in Radiation Oncology) Academy conference hosted in Paris, France on February 5th and 6th. (Logo: http://photos.prnewswire.com/prnh/20151126/291246LOGO ) (Photo: http://photos.prnewswire.com/prnh/20160108/320402 ) ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - This press release is intended for U.S. and EU audiences only. A separate press release has been prepared for use in Japan. With submission, Shire continues to strengthen its presence in Japan Shire plc (LSE: SHP, NASDAQ: SHPG) and Shionogi & Co., Ltd. recently announced that Shionogi submitted a New Drug Application (NDA) ...
Chertsey, England (ots/PRNewswire) - Poll conducted in advance of this year's ASTELLAS INNOVATION DEBATE(TM) also demonstrates public are open to an additional 'health tax' to support improved NHS services, but clinicians fear additional charges will hit the poorest hardest Although the NHS is ranked as one of the ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and U.S. based media - The Fertility Leader Merck receives market authorization from EMA for its advanced GONAL-f® prefilled pen for improved ease-of-use - Patients, nurses and doctors help to innovate and improve the design of a product which has already helped bring over two million babies into the world[1] Merck, a leading science and technology company, today ...